Human anti-PD-1 antibodies and uses therefor
First Claim
Patent Images
1. An isolated antibody or antigen-binding fragment thereof, comprising:
- a) a heavy chain variable region sequence comprising the three CDR sequences of SEQ ID NOs;
7-9;
orb) a light chain variable region sequence comprising the three CDR sequences of SEQ ID NOs;
10-12,wherein the isolated antibody, or antigen-binding fragment thereof, binds to a PD-1 protein having the amino acid sequence of SEQ ID NO;
2, and the isolated antibody, or antigen-binding fragment thereof, is chimeric, humanized, composite, or human.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention is based, in part, on the identification of novel human anti-PD-1, PD-L1, and PD-L2 antibodies. Accordingly, the invention relates to compositions and methods for diagnosing, prognosing, and treating conditions that would benefit from modulating PD-1, PD-L1, and/or PD-L2 activity (e.g., persistent infectious diseases, autoimmune diseases, asthma, transplant rejection, inflammatory disorders and tumors) using the novel human anti-PD-1, PD-L1, and PD-L2 antibodies described herein.
93 Citations
21 Claims
-
1. An isolated antibody or antigen-binding fragment thereof, comprising:
-
a) a heavy chain variable region sequence comprising the three CDR sequences of SEQ ID NOs;
7-9;
orb) a light chain variable region sequence comprising the three CDR sequences of SEQ ID NOs;
10-12,wherein the isolated antibody, or antigen-binding fragment thereof, binds to a PD-1 protein having the amino acid sequence of SEQ ID NO;
2, and the isolated antibody, or antigen-binding fragment thereof, is chimeric, humanized, composite, or human.- View Dependent Claims (2, 3, 4, 5, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)
-
-
6. An isolated nucleic acid encoding a polypeptide, wherein the polypeptide comprises a sequence selected from the group consisting of SEQ ID NOs:
- 25-33, or a sequence with at least about 95% homology to a sequence selected from the group consisting of SEQ ID NOs;
25-33.
- 25-33, or a sequence with at least about 95% homology to a sequence selected from the group consisting of SEQ ID NOs;
Specification